Related Experiment Video
Updated: Jul 2, 2025
09:01
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
342
Complement factor H: a novel innate immune checkpoint in cancer immunotherapy
Ruchi Saxena1, Elizabeth B Gottlin2, Michael J Campa2
1Department of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, United States.
Frontiers in Cell and Developmental Biology
|February 23, 2024
Summary
Immune system evasion by cancer is a major challenge. Complement factor H (CFH) acts as an innate immune checkpoint, promoting tumor growth by suppressing immune responses and creating an immunosuppressive tumor microenvironment.
Area of Science:
- Immunology
- Oncology
- Complement System Biology
Background:
- Cancer cell elimination relies on immune surveillance.
- Tumors develop evasion mechanisms, hindering immune monitoring and promoting progression.
- Complement factor H (CFH) is recognized as a key innate immune checkpoint in cancer.
Purpose of the Study:
- To review the role of CFH as an innate immune checkpoint in cancer.
- To explore the molecular mechanisms, immune cell interactions, and clinical implications of CFH in cancer.
- To discuss therapeutic strategies targeting CFH in cancer immunotherapy.
Main Methods:
- Literature review of existing research on CFH in cancer immunology.
- Analysis of molecular pathways and immune cell interactions mediated by CFH.
- Evaluation of clinical data and therapeutic potential of targeting CFH.
Main Results:
- CFH actively suppresses immune responses against tumors.
- CFH promotes immune evasion and establishes an immunosuppressive tumor microenvironment.
- CFH plays a significant role in tumor progression and resistance to immune attack.
Conclusions:
- CFH is a critical innate immune checkpoint that facilitates cancer progression.
- Targeting CFH presents a promising avenue for novel cancer immunotherapies.
- Further research is needed to overcome challenges and optimize CFH-targeted therapeutic strategies.
Keywords:
complementcomplement factor Himmune checkpointimmunosuppressionimmunotherapytumor micro-environmentMore Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:30Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
01:27Cytotoxic T Cells-mediated Immune Response
910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910